Cost-Effectiveness of Venous Thromboembolism Prophylaxis With a New Mobile Device After Total Hip Arthroplasty
Journal of Arthroplasty, 05/31/2012
Colwell CW et al. – The model showed a cost–effectiveness advantage of the compression device resulting in a savings of more than $3.69 million in a 10000–patient cohort. The result was primarily driven by a decrease in the amount of major bleeding, which requires significant health care resources to treat.